Contents
Current Pharmacogenomics, Volume 3 - Number 1
Saccharomyces Cerevisiae as a Genetic Model in Anticancer Therapy
, 3(1): 1 - 7J. E. Kurtz, P. Dufour, J. P. Bergerat and F. Exinger
DOI: 10.2174/1570160053175045
The Genetic Regulation of ADPRT/PARP-1 in Aging and Cancer Susceptibility
, 3(1): 9 - 19Kristin L. Lockett, Isaac V. Snowhite and Jennifer J. Hu
DOI: 10.2174/1570160053175054
Bilirubin and the Genome: The Hereditary Basis of Unconjugated Neonatal Hyperbilirubinemia
, 3(1): 21 - 42Michael Kaplan and Cathy Hammerman
DOI: 10.2174/1570160053174992
Influence of CYP2D6 Genetics on Opioid Kinetics, Metabolism and Response
, 3(1): 43 - 52Gerd Mikus and Johanna Weiss
DOI: 10.2174/1570160053175018
Multigenic Control of Drug Response and Regulatory Decision-Making in Pharmacogenomics: The Need for an Upper-Bound Estimate of Genetic Contributions
, 3(1): 53 - 71V. Ozdemir, W. Kalow, L. Tothfalusi, L. Bertilsson, L. Endrenyi and J. E. Graham
DOI: 10.2174/1570160053175027
DNA Methylation in the Pathogenesis of Systemic Lupus Erythematosus
, 3(1): 73 - 78Amr H. Sawalha and Bruce Richardson
DOI: 10.2174/1570160053174983
Webmaster Contact: info@benthamscience.net